首页>
外国专利>
Sulphanilamide derivs - by catalytic hydrogenation of corresp alkenyl derivs-hypoglycaemic activity
Sulphanilamide derivs - by catalytic hydrogenation of corresp alkenyl derivs-hypoglycaemic activity
展开▼
机译:磺胺甲酰胺衍生物-通过相应的烯基衍生物的催化氢化降低血糖活性
展开▼
页面导航
摘要
著录项
相似文献
摘要
New cpds. of formula (I): (where R1 = alkyl (3-5C) or cycloalkyl(5-7C); R2 = methyl or ethyl; or acid -addn. salts of (I) are prepd. by reduction of a cpd. (II): 1: - NH2 is - X and R1 is R1' where R1' = alkenyl (3-5C) or cycloalkenyl(5-7C); X = amino or a residue which can be hydrolyses, reduced etc. to a free amino group. reduction pref. using H2 in the presence of a catalyst (I) have hypoglycaemic activity, esp. 1-sulphanilyl-2-imino-3-butyl-5-ethyl-imidazolidine shows this activity upon peroral or parenteral administration and may be used in the treatment of diabetes.
展开▼
机译:新的cpds。式(I)的通式:(其中R 1 =烷基(3-5C)或环烷基(5-7C); R 2 =甲基或乙基;或酸加成(I)的盐通过将cpd还原而制备。 II):1:-NH 2是-X,R 1是R 1',其中R 1'=烯基(3-5C)或环烯基(5-7C); X =氨基或可水解,还原等成游离基的残基在催化剂存在下使用H2还原氨基基团(I)具有降血糖活性,尤其是1-磺基甲磺酰基-2-亚氨基-3-丁基-5-乙基-咪唑烷在口服或肠胃外给药时均具有这种降血糖活性,可能用于治疗糖尿病。
展开▼